| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 01/15/2002 | US6339091 Useful in therapy of of viral infections, parasitic diseases and cancer |
| 01/15/2002 | CA2039826C Spiro bridged and unbridged heterocyclic compounds |
| 01/10/2002 | WO2002002562A2 Heteropolycyclic inhibitors |
| 01/10/2002 | WO2002002549A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | WO2002002541A2 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | WO2002002108A1 Inhibitors of prenyl-protein transferase |
| 01/10/2002 | WO2002002090A2 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | WO2001036425A3 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 01/10/2002 | US20020004595 Process for preparing potassium clavulanate |
| 01/10/2002 | US20020004487 Novel erythromycins and process for their preparation |
| 01/10/2002 | CA2414885A1 Heteropolycyclic inhibitors |
| 01/10/2002 | CA2414807A1 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | CA2414799A1 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | CA2412287A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/09/2002 | EP1170273A1 Alkynic compounds, their use as monomers in vacuum deposition polymerisation, thin films formed from these polymers and their use in electroluminescent devices |
| 01/09/2002 | CN1330654A 4,5-pyrrolo-oxindoles |
| 01/03/2002 | WO2002000626A1 Fused azepine derivatives and their use as antidiuretic agents |
| 01/03/2002 | WO2001066544A3 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 01/03/2002 | US20020002173 E. g., 6-(3-chlorophenyl)-1,4-dihydro-4,4-dimethyl-2H-thieno-(2,3-d)(1,3)oxazine-2 -one; agonists and antagonists of the progesterone receptor; inducing contraception and treating or preventing benign or malignant neoplastic diseases |
| 01/03/2002 | US20020002165 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 01/03/2002 | CA2412555A1 Fused azepine derivatives and their use as antidiuretic agents |
| 01/02/2002 | EP1165567A2 Sulfamate containing macrocyclic immunomodulators |
| 01/02/2002 | EP1165563A1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents |
| 01/02/2002 | CN1329668A Polyketide synthase enzymes and recombinant DNA constructs therefor |
| 01/01/2002 | US6335358 Lactacystin analogs |
| 01/01/2002 | US6335356 Method of treating a patient by parenteral administration of a lipophilic compound |
| 01/01/2002 | CA2285886C Compounds containing oxadiazolopyrimidines destined to be used for slowing down hair loss and for inducing and stimulating their growth |
| 01/01/2002 | CA2087859C Benzopyran derivatives |
| 01/01/2002 | CA2024156C Compositions for use in controling the shedding of hair and in the induction and stimulation of its growth, such compositions containing 2-amino pyrimidine 3-oxide derivatives andnovel 2-amino pyrimidine 3-oxide derivative compounds |
| 12/27/2001 | WO2001098306A1 Compounds for treating impaired fundic relaxation |
| 12/27/2001 | WO2001097809A2 Method of treating cardiovascular disease using rapamycin |
| 12/27/2001 | WO2001057042A3 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 12/27/2001 | CA2412636A1 Method of treating cardiovascular disease using rapamycin |
| 12/26/2001 | CN1328462A Use of staurosporine derivatives for treating ocular neovascular diseases |
| 12/26/2001 | CN1328461A Method for preventing/treating damage to sensory hair cells and cochlear neurons |
| 12/26/2001 | CN1328455A Use of N-substituted azabicycloalkane derivatives for treating diseases of central nervous system |
| 12/25/2001 | US6333410 Process for the preparation and purification of thiol-containing maytansinoids |
| 12/25/2001 | US6333334 Use of macrolide compounds for the treatment of ARDS |
| 12/20/2001 | WO2001096346A1 Tricyclic compounds as mrp1-inhibitors |
| 12/20/2001 | WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096307A2 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 12/20/2001 | US20010053853 Alkanoic acid derivative; integrin receptor antagonist |
| 12/20/2001 | US20010053779 Antiinflammatory agents; respiratory system disorders |
| 12/20/2001 | CA2411813A1 Tricyclic compounds as mrp1-inhibitors |
| 12/19/2001 | EP1163240A1 Tricyclic benzoylpyrazole derivatives used as a herbicide |
| 12/18/2001 | US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control |
| 12/18/2001 | US6331631 Reacting 4-piperidinocarboxamide and 1-bromobutane, reduction with lithium aluminum hydride using toluene as solvent |
| 12/18/2001 | US6331547 Polyoxyethylene glycol conjugate with 40-o-(2-hydroxy)ethyl-rapamycin; immunosuppressive, antiinflammatory, antifungal, antiproliferative and antitumor agent |
| 12/13/2001 | WO2000009509A9 Process for the large-scale synthesis of 4,10-dinitro -2,6,8,12- tetraoxa- 4,10-diazatetracyclo- [5.5.0.0?5,903,11¿]- dodecane |
| 12/12/2001 | EP0656893B1 Photochromic oxazine compounds |
| 12/11/2001 | US6329386 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 12/11/2001 | US6329376 Inhibitors of prenyl-protein transferase |
| 12/11/2001 | US6328970 Rapamycin position 27 conjugates |
| 12/05/2001 | EP1158995A1 Biologically active compounds of ganoderma pfeifferi dms 13239 |
| 12/05/2001 | EP1158984A1 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP0994693B1 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 12/04/2001 | US6326382 Cholinesterase inhibitors; useful in enhancing memory in patients suffering from dementia and alzheimer's disease |
| 12/04/2001 | CA2046880C Substituted alkylamide derivatives of teicoplanin |
| 11/29/2001 | WO2001090110A1 Macrolides |
| 11/29/2001 | US20010046989 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 11/28/2001 | EP1157024A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors |
| 11/28/2001 | EP0630898B1 Thrombocytopenia remedy |
| 11/28/2001 | CN1075499C Quninolone-acid naphthyridone carboxylic acid derivatives |
| 11/27/2001 | US6323200 The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the t-helper-type 2 immune response. |
| 11/27/2001 | US6323197 Non-competitive inhibiting of the ampa receptors, these compounds can be used as medicaments for treatment of the central nervous system |
| 11/22/2001 | WO2001087892A1 Crf receptor antagonists |
| 11/22/2001 | WO2001087891A1 Process for the purification of a salt of clavulanic acid |
| 11/22/2001 | WO2001087889A1 Crf receptor antagonists and methods relating thereto |
| 11/22/2001 | WO2001087886A1 Crf receptor antagonists and methods relating thereto |
| 11/22/2001 | WO2001087884A2 Polyketide derivatives |
| 11/22/2001 | WO2001087859A1 Naphthol derivatives |
| 11/22/2001 | WO2001087845A2 N-containing heterocyclic compounds and their use as 5-ht antagonists |
| 11/22/2001 | WO2001087830A2 Substituted thioacetamides |
| 11/22/2001 | WO2001087376A1 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 11/22/2001 | WO2001087374A1 Delivery systems for treatment of vascular disease |
| 11/22/2001 | WO2001087373A1 Delivery devices for treatment of vascular disease |
| 11/22/2001 | WO2001087342A2 Delivery devices for treatment of vascular disease |
| 11/22/2001 | WO2001087283A2 New use of citreamicins |
| 11/22/2001 | WO2001087263A2 Delivery systems for treatment of vascular disease |
| 11/22/2001 | WO2001029050A3 Condensed pyrrole derivatives as neuraminidase inhibitors |
| 11/22/2001 | WO2001027116A3 Condensed dihydroquinolinone derivatives for inhibiting mrp1 |
| 11/22/2001 | WO2001025239A3 Oxazinoquinolones useful for the treatment of viral infections |
| 11/22/2001 | US20010044539 (2S,3Z)-2-amino-5-(6,7,8,9-tetrahydro-3-oxo-3H,5H -(1,2,4)oxadiazolo(4,3-a)azepin-5-yl)-3-pentenoic acid, for example |
| 11/22/2001 | US20010044435 Antitumor agents, treatment of the lungs and respiratory tract |
| 11/22/2001 | CA2409116A1 Substituted thioacetamides |
| 11/22/2001 | CA2408837A1 New use of citreamicins |
| 11/22/2001 | CA2408729A1 Delivery systems for treatment of vascular disease |
| 11/22/2001 | CA2408719A1 Antiproliferative drug and delivery device |
| 11/22/2001 | CA2408608A1 Antiinflammatory drug and delivery device |
| 11/22/2001 | CA2407259A1 Polyketide derivatives |
| 11/21/2001 | EP1155001A1 Isoquinoline derivatives and isoquinoline combinatorial libraries |
| 11/21/2001 | EP0918774B1 Androgen receptor modulator compounds and methods |
| 11/21/2001 | EP0745081B1 indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
| 11/21/2001 | CN1323310A Photocyclized rapamycins |
| 11/20/2001 | CA2176668C Heterocyclic spiro compounds, process for preparing the same and pharmaceutical compositions containing them |
| 11/20/2001 | CA2024843C Synthesis of mannojirimycin derivatives |
| 11/20/2001 | CA2018287C Use of rapamycin for preparing a composition for inhibiting organ or tissue transplant rejection, and composition for inhibiting transplant rejection |
| 11/15/2001 | WO2001085734A1 Benzoxazines for use in the treatment of parkinson's disease |
| 11/15/2001 | WO2001085729A1 Novel vitronectin receptor antagonists |
| 11/15/2001 | WO2001085722A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors |